Black Diamond Therapeutics, Inc.
BDTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001701541
No open-market purchases or sales by Black Diamond Therapeutics, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $64.9M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Black Diamond Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- −11 vs. Q1 2021
- Shares held
- 25.4M
- −3.69M (−12.7%) vs. Q1 2021
- Total value
- $309.6M
- −$395.9M (−56.1%) vs. Q1 2021
- New holders
- 24
- 41 more added
- Sold out
- 35
- 13 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 96 | $64.9M |
| Q1 2026 | 104 | $82.0M |
| Q4 2025 | 104 | $92.0M |
| Q3 2025 | 91 | $147.0M |
| Q2 2025 | 94 | $95.8M |
| Q1 2025 | 85 | $63.0M |
| Q4 2024 | 88 | $102.5M |
| Q3 2024 | 96 | $211.9M |
| Q2 2024 | 90 | $217.9M |
| Q1 2024 | 88 | $199.9M |
| Q4 2023 | 76 | $107.1M |
| Q3 2023 | 73 | $106.8M |
| Q2 2023 | 74 | $209.2M |
| Q1 2023 | 50 | $40.6M |
| Q4 2022 | 59 | $37.9M |
| Q3 2022 | 69 | $36.3M |
| Q2 2022 | 74 | $52.9M |
| Q1 2022 | 87 | $63.5M |
| Q4 2021 | 95 | $123.7M |
| Q3 2021 | 101 | $206.3M |
| Q2 2021 | 102 | $309.6M |
| Q1 2021 | 113 | $705.5M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Black Diamond Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $42.1M | 0.55% | 00.0% | Unchanged |
| Bellevue Group AG | 3,463,000 | $42.2M | 0.41% | +1,220,000+54.4% | Added |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −553,774−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −440,000−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −360,356−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −300,107−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −265,580−100.0% | Sold out |
| Peregrine Capital Management LLC | 0 | $0 | 0.00% | −184,253−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −142,911−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −140,232−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −101,474−100.0% | Sold out |
| ArrowMark Colorado Holdings LLC | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −67,853−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −59,863−100.0% | Sold out |
| Aviva PLC | 0 | $0 | 0.00% | −53,080−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −36,700−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −28,448−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −26,770−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −24,400−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −20,770−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −18,600−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −12,307−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −10,405−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −10,203−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −9,293−100.0% | Sold out |
| HC Advisors, LLC | 0 | $0 | 0.00% | −8,330−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −8,290−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −8,148−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −5,594−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −2,369−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −651−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −247−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Sargent Bickham Lagudis LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |